Showing results (401-410 of 439) with videos related to

Sort By:
Pageof 44
Liver International : Official Journal of the International Association for the Study of the Liver|August 19, 2007
Monocyte-derived dendritic cells from chronic HCV patients are not infected but show an immature phenotype and aberrant cytokine profileHuub C Gelderblom, Laurens E J Nijhuis, Esther C de Jong, et al.
Journal of Viral Hepatitis|January 29, 2008
HCV-specific T-cell responses in injecting drug users: evidence for previous exposure to HCV and a role for CD4+ T cells focussing on nonstructural proteins in viral clearanceT A Ruys, N M Nanlohy, C H S B van den Berg, et al.
Vaccine|May 12, 2009
Suitability of PER.C6 cells to generate epidemic and pandemic influenza vaccine strains by reverse geneticsW Koudstaal, L Hartgroves, M Havenga, et al.
Journal of Biomaterials Applications|November 21, 2013
Influence of scaffold composition over in vitro osteogenic differentiation of hBMSCs and in vivo inflammatory responseAna R Costa-Pinto, I Vargel, K Tuzlakoglu, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|June 6, 2025
Pro-ictal, rather than pre-ictal, brain state marked by global critical slowing and local gamma power increaseI Dallmer-Zerbe, J Kopal, A Pidnebesna, et al.
Biotechnology and Bioengineering|June 3, 2008
Serum-free transient protein production system based on adenoviral vector and PER.C6 technology: high yield and preserved bioactivityM J E Havenga, L Holterman, I Melis, et al.
AIDS (London, England)|January 12, 2001
Slower decline of plasma HIV-1 RNA following highly suppressive antiretroviral therapy in primary compared with chronic infectionH Putter, J M Prins, S Jurriaans, et al.
AIDS (London, England)|August 26, 1998
Alternative multidrug regimen provides improved suppression of HIV-1 replication over triple therapyG J Weverling, J M Lange, S Jurriaans, et al.
Cancer Gene Therapy|November 4, 2006
Human adenovirus type 35 vector for gene therapy of brain cancer: improved transduction and bypass of pre-existing anti-vector immunity in cancer patientsE Brouwer, M J Havenga, O Ophorst, et al.
AIDS Research and Human Retroviruses|October 29, 2000
Evaluation of a second-generation nucleic acid sequence-based amplification assay for quantification of HIV type 1 RNA and the use of ultrasensitive protocol adaptationsD W Notermans, F de Wolf, P Oudshoorn, et al.
Pageof 44